EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Targeting Topoisomerase I and DNA with LCS1269 Drives Glioblastoma Cell Death Despite ATM/Chk1/BRCA1/RAD51 Signaling Pathway Activation

Nikolay Kalitin, Ekaterina Savchenko, Nadezhda Samoylenkova, Natalia Koroleva iD, Anna Lushnikova, Aida Karamysheva, Galina Pavlova iD

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms26136014 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Nikolay Kalitin und 6 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Tumor Cell Genetics, N.N. Blokhin National Medical Research Center of Oncology, 115522 Moscow, Russia. Hauptthemen laut MEDLINE: Glioblastoma, Signal Transduction, DNA Topoisomerases, Type I, Brain Neoplasms. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the Ministry of Science and Higher Education of the Russian Federation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Glioblastoma (GBM) is the most aggressive primary brain tumor in adults. The success of modern multimodal standards approved in anti-glioblastoma therapy remains limited. Consequently, new therapeutics are urgently needed. In this study, utilizing ex vivo, in silico, and in vitro approaches, we investigated the LCS1269 effects on two potential targets, DNA and Top I. We also elucidated the influence of LCS1269 on signaling pathways and GBM cell viability. Based on our docking data and competition studies results, we demonstrated that LCS1269 may bind to DNA, demonstrating selectivity toward AT-rich regions. We also showed that LCS1269 could dock both Top I/DNA binary complex and Top I active sites. LCS1269 caused Top I dysfunction and downregulated the expression of Top I. Moreover, the LCS1269 treatment of GBM cells facilitated DNA damage and the activation of the ATM/Chk1/BRCA1/Rad51 pathway. Meanwhile, DNA damage response induction and ATM/Chk1/BRCA1/Rad51 pathway activation were insufficient to prevent GBM cell death triggered by LCS1269 treatment. Our work shows that DNA and Top I are promising molecular targets of LCS1269, thus providing insight on several novel mechanisms of its anti-tumor activity. Nonetheless, we did not perform a biophysical validation of the LCS1269–DNA interaction, which is a limitation of our study.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GlioblastomaSignal TransductionDNA Topoisomerases, Type IBrain NeoplasmsTopoisomerase I InhibitorsDNAHumansCell Line, TumorAtaxia Telangiectasia Mutated ProteinsCheckpoint Kinase 1BRCA1 ProteinRad51 RecombinaseDNA DamageCell Death

Stichwörter der Autor:innen

ATMBRCA1Chk1DNA damageLCS1269Topoisomerase Iglioblastoma

Substanzen

Ataxia Telangiectasia Mutated ProteinsCheckpoint Kinase 1BRCA1 ProteinDNA Topoisomerases, Type IRad51 RecombinaseCHEK1 protein, humanATM protein, humanBRCA1 protein, humanRAD51 protein, humanTopoisomerase I Inhibitors

Autor:innen und Institutionen

  • Laboratory of Tumor Cell Genetics, N.N. Blokhin National Medical Research Center of Oncology, 115522 Moscow, Russia.
  • Laboratory of Molecular and Cellular Neurogenetics, N.N. Burdenko National Medical Research Center of Neurosurgery, 125047 Moscow, Russia.
  • Laboratory of Oncogenomics, N.N. Blokhin National Medical Research Center of Oncology, 115522 Moscow, Russia.
  • Laboratory of Neurogenetics and Developmental Genetics, Institute of Higher Nervous Activity and Neurophysiology of RAS, 117485 Moscow, Russia.

ORCID-Profile: Natalia Koroleva, Galina Pavlova

Förderung

  • the Ministry of Science and Higher Education of the Russian Federation

Zitieren

APA

Kalitin, N., Savchenko, E., Samoylenkova, N., Koroleva, N., Lushnikova, A., Karamysheva, A., & Pavlova, G. (2025). Targeting Topoisomerase I and DNA with LCS1269 Drives Glioblastoma Cell Death Despite ATM/Chk1/BRCA1/RAD51 Signaling Pathway Activation. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26136014

Vancouver

Kalitin N, Savchenko E, Samoylenkova N, Koroleva N, Lushnikova A, Karamysheva A, et al. Targeting Topoisomerase I and DNA with LCS1269 Drives Glioblastoma Cell Death Despite ATM/Chk1/BRCA1/RAD51 Signaling Pathway Activation. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26136014

BibTeX
@article{Kalitin2025,
  author = {Kalitin, Nikolay and Savchenko, Ekaterina and Samoylenkova, Nadezhda and Koroleva, Natalia and Lushnikova, Anna and Karamysheva, Aida and Pavlova, Galina},
  title = {Targeting Topoisomerase I and DNA with LCS1269 Drives Glioblastoma Cell Death Despite ATM/Chk1/BRCA1/RAD51 Signaling Pathway Activation},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms26136014}
}
Kostenlos starten →